Inactive Instrument

Epsilon Healthcare Limited Stock Other OTC

Equities

HDRPF

AU0000137598

Pharmaceuticals

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2021 5.5M 3.63M Sales 2022 7.11M 4.7M Capitalization 7.51M 4.96M
Net income 2021 -9M -5.95M Net income 2022 -13M -8.59M EV / Sales 2021 3.26 x
Net Debt 2021 2.1M 1.39M Net Debt 2022 2.34M 1.54M EV / Sales 2022 1.38 x
P/E ratio 2021
-1.48 x
P/E ratio 2022
-0.38 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 60.39%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - Nov. 20
Comptroller/Controller/Auditor - -
Corporate Secretary 60 22-12-22
Members of the board TitleAgeSince
Chairman - 16-08-28
Director/Board Member - 22-10-26
Chairman - 22-10-27
More insiders
Epsilon Healthcare Limited is an Australia-based global healthcare and pharmaceuticals company. The Company has a diversified and vertically integrated portfolio of assets, including healthcare and pharmaceutical contract development and manufacturing. The Company’s segments include the manufacture and distribution of hydroponics equipment, materials and nutrients, and the development and delivery of medicinal cannabis. The Company owns medicinal cannabis assets, including the GMP cannabis manufacturing facility in the Southern Hemisphere (the Southport Facility) in Southport, Australia, and the Tetra Health clinic group. The Company also provides advisory services related to medicinal cannabis. The Company’s subsidiaries include Dragon Vision Limited, Canndeo Pty Ltd, Canna Clinics Pty Ltd, THC Pharma Pty Ltd, Metra Holdings Pty Ltd, Tetra Pty Ltd, Medimar Pty Ltd and Demimar Pty Ltd.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW